Drugs / C-10299
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01458769 Comparator | Dec 2010 → Apr 2011 | — | Concert Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-10299 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01458769 ↗ |
| Route | Oral | “C-10299 200 mg, oral, single dose” NCT01458769 ↗ |